4 Biggest Biotech Disasters Of 2013

Biotechnology stocks have been among the best performing investment vehicles throughout much of 2013.  With the momentum still firmly in tact as we head into 2014, investors are likely licking their chops for additional gains.  Unfortunately, the industry does carry abnormal risk and four stocks suffered the cruel fate of failure in a year when it was hard not to win.  The four stocks that suffered catastrophic drops in value were Amarin Corporation (NASDAQ:AMRN), Ariad Pharmaceuticals (NASDA...